Table 3. Effect of EL 2037T/C genotypes on serum lipid levels (TT vs. TC+CC).

Genotypes	TC (mmol/L)	TG (mmol/L)	HDL-C (mmol/L)	LDL-C (mmol/L)	Apo A1 (g/L)	ApoB (g/L)	LP(a) (g/L)
All #
TT (n = 602)	4.51± 0.98	1.82± 1.22	1.09± 0.29	2.73± 0.82	1.22± 0.26	0.92± 0.27	0.23± 0.27
TC+CC (n = 404)	4.56± 0.98	1.87± 1.43	1.14± 0.33	2.74± 0.83	1.22± 0.25	0.93± 0.31	0.24± 0.30
P	0.794	0.831	0.023	0.884	0.748	0.736	0.452
CAD subgroup
TT (n = 435)	4.54± 1.01	1.80± 1.19	1.07± 0.27	2.81± 0.86	1.21± 0.27	0.93± 0.27	0.23± 0.26
TC+CC (n = 257)	4.55± 0.97	1.99± 1.54	1.07± 0.29	2.80± 0.89	1.19± 0.23	0.95± 0.30	0.26± 0.29
P	0.666	0.244	0.846	0.896	0.349	0.529	0.123
Control subgroup
TT (n = 167)	4.44± 0.89	1.86± 1.31	1.16± 0.32	2.53± 0.68	1.24± 0.21	0.89± 0.25	0.23± 0.27
TC+CC (n = 147)	4.58± 0.99	1.66± 1.21	1.25± 0.37	2.62± 0.72	1.28± 0.26	0.89± 0.32	0.21± 0.31
P	0.177	0.103	0.016	0.195	0.139	0.914	0.500
Male subgroup
TT (n = 396)	4.42± 1.00	1.81± 1.34	1.06± 0.29	2.70± 0.88	1.17± 0.23	0.91± 0.28	0.22± 0.26
TC+CC (n = 262)	4.41± 0.92	1.82± 1.34	1.08± 0.32	2.68± 0.82	1.20± 0.28	0.90± 0.28	0.23± 0.26
P	0.497	0.643	0.481	0.794	0.191	0.909	0.572
Female subgroup
TT (n = 206)	4.69± 0.92	1.89± 1.20	1.16± 0.28	2.78± 0.76	1.27± 0.22	0.94± 0.26	0.24± 0.28
TC+CC (n = 142)	4.85± 1.02	1.87± 1.35	1.20± 0.31	2.87± 0.82	1.28± 0.24	0.97± 0.32	0.28± 0.36
P	0.450	0.304	0.218	0.287	0.759	0.366	0.302
< 60 years subgroup
TT (n = 230)	4.56± 1.01	2.02± 1.51	1.09± 0.29	2.72± 0.85	1.22± 0.22	0.93± 0.27	0.23± 0.28
TG+GG (n = 147)	4.49± 0.89	1.93± 1.51	1.15± 0.33	2.66± 0.73	1.23± 0.26	0.91± 0.33	0.21± 0.28
P	0.499	0.253	0.071	0.484	0.643	0.629	0.523
≥ 60 years subgroup
TT (n = 372)	4.48± 0.97	1.69± 0.99	1.10± 0.28	2.74± 0.81	1.21± 0.28	0.91± 0.26	0.23± 0.25
TG+GG (n = 257)	4.61± 1.02	1.84± 1.39	1.13± 0.33	2.78± 0.88	1.21± 0.25	0.93± 0.30	0.26± 0.31
P	0.286	0.491	0.139	0.501	0.933	0.402	0.156

#: Patients absent of lipid profiles was excluded.